Table 3.
Histological changes and p53 expression in relation to adjacent tumor type and tumor T stage.
| Nr | Dysplasia | Cuboid | Squamous | Hyperplasia | p53 Adjacent mucosa | p53 tumor | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Metaplasia | Metaplasia | 0–10% | 10–25% | 25–50% | 50–100% | <10% | >10% | ||||
| Papillary | 7 | 1 (17%) | 2 (29%) | 1 (17%) | 5 (83%) | 2 (29%) | 4 (57%) | 1 (14%) | 0 | 1 (14%) | 6 (84%) |
| Colonic | 23 | 5 (22%) | 16 (70%) | 5 (22%) | 5 (22%) | 16 (70%) | 6 (26%) | 1 (4%) | 0 | 3 (13%) | 20 (87%) |
| Solid | 4 | 0 | 3 (75%) | 0 | 0 | 2 (50%) | 2 (50%) | 0 | 0 | 0 | 4 (100%) |
| Mucinous | 17 | 1 (6%) | 8 (47%) | 6 (35%) | 6 (35%) | 7 (41%) | 4 (24%) | 5 (29%) | 1 (6%) | 7 (41%) | 10 (59%) |
|
| |||||||||||
| T1 | 15 | 2 (13%) | 9 (60%) | 2 (13%) | 7 (47%) | 11 (73%) | 3 (20%) | 1 (7%) | 0 | 4 (27%) | 11 (73%) |
| T2 | 5 | 1 (20%) | 3 (60%) | 0 | 2 (40%) | 2 (40%) | 2 (40%) | 1 (20%) | 0 | 2 (40%) | 3 (60%) |
| T3 | 17 | 2 (12%) | 9 (53%) | 6 (35%) | 11 (65%) | 10 (59%) | 5 (29%) | 1 (6%) | 1 (6%) | 4 (24%) | 13 (76%) |
| T4 | 14 | 2 (14%) | 8 (57%) | 4 (29%) | 7 (50%) | 4 (29%) | 7 (50%) | 3 (21%) | 0 | 2 (14%) | 12 (86%) |
P53 immunopositivity is presented as the number of cases that showed some positivity.